Diligence memo · auto-generated · as of July 2, 2026
PhysioSonics, Inc
PhysioSonics, Inc looks fair against its niche peers and is dormant on financing cadence.
Businessfiled
PhysioSonics, Inc operates in Biotechnology, based in BELLEVUE.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
PhysioSonics, Inc has raised $7.9M in disclosed capital across 4 recorded rounds, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $3.6M on 2011-01-25.
Most recent recorded round closed around 2012-07-31.
Valuation (modeled)modeled
Provath models PhysioSonics, Inc at approximately $67M (range $1.1M–$522M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Fair. Modeled value is 0.77× the median modeled value of Seed Biotechnology companies in 2010–2012 (151 peers) — value vs value, same stage and era. Within the normal band (77% of peer median) for its niche.
Financing rhythm & timingmixed
Historic cadence: a new round about every 12 months.
Last raise 13.9 yr ago; this sector typically re-raises about every 14 months.
Silent for over 3× the sector's normal cadence.
The last round was 2.4× smaller than the prior — a bridge or down round.
Comparablesmixed
Capital scale ranks ahead of 51% of Biotechnology peers (4291 compared).
Modeled value ranks above 51% of those peers.
Closest niche peers: Signum Biosciences, Inc., Denali Medical II, Inc., Health Elements, LLC, Nkt Therapeutics Inc, Surface Logix Inc.
Peoplefiled
14 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.